Royal Bank of Canada
EDIT icon

Royal Bank of Canada’s Editas Medicine EDIT Stock Holding History

Royal Bank of Canada’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18K Sell
7,506
-4,725
-39% -$10K ﹤0.01% 5939
2025
Q4 		$25K Sell
12,231
-345,988
-97% -$999K ﹤0.01% 5912
2025
Q3 		$1.24M Buy
358,219
+49,668
+16% +$139K ﹤0.01% 3798
2025
Q2 		$678K Buy
308,551
+287,730
+1,382% +$471K ﹤0.01% 4229
2025
Q1 		$24K Sell
20,821
-5,966
-22% -$8.78K ﹤0.01% 5851
2024
Q4 		$34K Sell
26,787
-141
-0.5% -$359 ﹤0.01% 5871
2024
Q3 		$91K Sell
26,928
-874
-3% -$3.81K ﹤0.01% 5406
2024
Q2 		$129K Buy
27,802
+6,572
+31% +$37.1K ﹤0.01% 5103
2024
Q1 		$159K Sell
21,230
-21,121
-50% -$175K ﹤0.01% 4870
2023
Q4 		$429K Buy
42,351
+129
+0.3% +$1.13K ﹤0.01% 4402
2023
Q3 		$330K Buy
42,222
+12,844
+44% +$110K ﹤0.01% 4365
2023
Q2 		$242K Buy
29,378
+7,188
+32% +$62.6K ﹤0.01% 4568
2023
Q1 		$161K Sell
22,190
-51,265
-70% -$456K ﹤0.01% 4799
2022
Q4 		$652K Sell
73,455
-2,930
-4% -$32.2K ﹤0.01% 3860
2022
Q3 		$935K Buy
76,385
+2,154
+3% +$33.6K ﹤0.01% 3518
2022
Q2 		$879K Sell
74,231
-2,621
-3% -$35.1K ﹤0.01% 3626
2022
Q1 		$1.46M Buy
76,852
+15,684
+26% +$292K ﹤0.01% 3332
2021
Q4 		$1.63M Buy
61,168
+9,434
+18% +$325K ﹤0.01% 3346
2021
Q3 		$2.13M Sell
51,734
-10,791
-17% -$591K ﹤0.01% 3031
2021
Q2 		$3.54M Buy
62,525
+12,087
+24% +$446K ﹤0.01% 2558
2021
Q1 		$2.12M Sell
50,438
-69,457
-58% -$3.96M ﹤0.01% 2952
2020
Q4 		$8.41M Buy
119,895
+57,666
+93% +$2.37M ﹤0.01% 1842
2020
Q3 		$1.75M Sell
62,229
-2,857
-4% -$93K ﹤0.01% 2803
2020
Q2 		$1.93M Buy
65,086
+6,786
+12% +$177K ﹤0.01% 2646
2020
Q1 		$1.16M Buy
58,300
+1,185
+2% +$29.9K ﹤0.01% 2911
2019
Q4 		$1.69M Sell
57,115
-8,524
-13% -$213K ﹤0.01% 3027
2019
Q3 		$1.49M Buy
65,639
+239
+0.4% +$5.92K ﹤0.01% 2993
2019
Q2 		$1.62M Buy
65,400
+4,005
+7% +$95.6K ﹤0.01% 2921
2019
Q1 		$1.5M Buy
61,395
+9,913
+19% +$224K ﹤0.01% 2897
2018
Q4 		$1.17M Sell
51,482
-2,675
-5% -$72.8K ﹤0.01% 3037
2018
Q3 		$1.72M Buy
54,157
+41
+0.1% +$1.32K ﹤0.01% 2955
2018
Q2 		$1.94M Buy
54,116
+16,500
+44% +$584K ﹤0.01% 2755
2018
Q1 		$1.25M Buy
37,616
+17,494
+87% +$623K ﹤0.01% 3010
2017
Q4 		$619K Buy
20,122
+6,264
+45% +$158K ﹤0.01% 3637
2017
Q3 		$333K Buy
13,858
+4,494
+48% +$85.5K ﹤0.01% 4125
2017
Q2 		$157K Buy
9,364
+372
+4% +$6.7K ﹤0.01% 4506
2017
Q1 		$201K Buy
8,992
+2,496
+38% +$51.7K ﹤0.01% 4333
2016
Q4 		$105K Buy
6,496
+3,517
+118% +$53.4K ﹤0.01% 4845
2016
Q3 		$40K Buy
2,979
+2,429
+442% +$49.8K ﹤0.01% 5256
2016
Q2 		$13K Sell
550
-4,175
-88% -$141K ﹤0.01% 5655
2016
Q1 		$164K Buy
+4,725
New +$124K ﹤0.01% 4484

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada's EDIT Position: Q1 2026 in Review

Royal Bank of Canada reduced its Editas Medicine (EDIT) stake by 39% in Q1 2026, selling an estimated $10K and leaving 7,506 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #5939.

Royal Bank of Canada first reported a position in EDIT in Q1 2016 and has held it in 41 quarters since. The position peaked at $8.41M in Q4 2020. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Royal Bank of Canada held 7,506 shares of Editas Medicine worth $18K as of Q1 2026.
  • Royal Bank of Canada sold 4,725 Editas Medicine shares in Q1 2026, an estimated $10K.
  • Editas Medicine made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5939 holding.
  • Royal Bank of Canada first reported a position in Editas Medicine in Q1 2016 and has held it in 41 quarters since.
  • Royal Bank of Canada's Editas Medicine position peaked at $8.41M in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.